PDF herunterladen
Thromb Haemost 2000; 84(03): 514
DOI: 10.1055/s-0037-1614060
Letters to the Editor
Schattauer GmbH

Influence of Fluvastatin on Levels of von Willebrand Factor in Cardiac Transplant Recipients

A. D. Blann
1   From the Haemostasis, Thrombosis and Vascular Biology Unit, City Hospital, University Dept. of Medicine, Birmingham, UK
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 10. April 2000

Accepted 17. April 2000

Publikationsdatum:
14. Dezember 2017 (online)

Auch verfügbar auf
    Lizenzen und Reprints

 

 

  • References

  • 1 Ambrosi P, Aillaud MF, Habib G, Kreitmann B, Matras D, Luccioni R, Bouvenot G, Juhan-Vague I. Fluvastatin decreases soluble thrombomodulin in cardiac transplant recipients. Thromb Haemost 2000; 83: 46-8.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 2 Collins P, Wilkie M, Razak K, Abbott S, Harley S, Bax C, Zaidi M, Blake D, Cunningham J, Newland A. Cyclosporin and cremaphor modulate von Willebrand factor release from cultured endothelial cells. Transplantation 1993; 56: 1218-23.
    CrossrefPubMedGoogle Scholar
  • 3 Licciardello JTW, Moake JL, Rudy CK, Karp DD, Hong WK. Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology 1985; 42: 296-300.
    CrossrefPubMedGoogle Scholar
  • 4 Richard S, Seigneur M, Blann A, Adams R, Renard M, Puntous M, Boiron JM, Amiral J, Reiffers J, Boisseau M. Vascular endothelial lesion in patients undergoing bone marrow transplantation. Bone Marrow Transplant 1996; 18: 955-9.
    PubMedGoogle Scholar